REVIEW article

Front. Physiol., 26 January 2021

Sec. Integrative Physiology

Volume 11 - 2020 | https://doi.org/10.3389/fphys.2020.625110

COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology

  • 1. Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France

  • 2. Centre des Sciences du Goût et de l’Alimentation, AgroSup Dijon, CNRS UMR6265, INRAE UMR 1324, Université de Bourgogne Franche Comté, Dijon, France

  • 3. Department of Clinical Neurophysiology, University Hospital, Dijon, France

  • 4. STROMALab, Université de Toulouse, CNRS ERL 5311, Inserm U1031, Université Paul Sabatier (UPS), Toulouse, France

Abstract

Smell and taste impairments are recognized as common symptoms in COVID 19 patients even in an asymptomatic phase. Indeed, depending on the country, in up to 85–90% of cases anosmia and dysgeusia are reported. We will review briefly the main mechanisms involved in the physiology of olfaction and taste focusing on receptors and transduction as well as the main neuroanatomical pathways. Then we will examine the current evidences, even if still fragmented and unsystematic, explaining the disturbances and mode of action of the virus at the level of the nasal and oral cavities. We will focus on its impact on the peripheral and central nervous system. Finally, considering the role of smell and taste in numerous physiological functions, especially in ingestive behavior, we will discuss the consequences on the physiology of the patients as well as management regarding food intake.

Introduction

In the list of clinical symptoms of COVID-19, a sudden loss of sense of smell and taste has been identified (). This is now recognized as a “significant symptom” that can be found even in the absence of the “usual symptoms” such as fever, cough, respiratory failure. While reports were at first anecdotal and generally without quantitative measurements, a recent study on around 4,000 participants from more than 40 countries confirms that COVID-19 broadly impacts chemosensory function across multiple sensory modalities (). A major reduction in smell, independently of nasal obstruction, and in taste was reported without significant differences between participants tested in laboratory or by clinical assessment via a multi-lingual questionnaire (von Bartheld et al., 2020).

In this review we will describe (i) the main mechanism and neurological pathways underlying olfaction and taste, (ii) the current hypothesis to explain the pathophysiology of anosmia and ageusia, and (iii) the physiological consequences these defects can have, with a focus on feeding behavior.

Physiology of Olfaction and Taste

Olfaction, taste and chemesthesis are the three separate modalities involved in food flavor perception. Olfaction is involved in the detection of volatile chemical compounds present in the environment or in the oral cavity (by retronasal olfaction), whereas taste (gustation) is involved in the chemical detection of soluble compounds by taste detectors present in taste buds. Chemesthesis, also referred as trigeminal chemosensation, is the chemical sense allowing the detection of another class of taste-related compounds, producing sensations of irritation pungency, burning, tingling or coolness, which can be part of flavor perception (Roper, 2014).

Odorant molecules are detected by a complex self-regenerating olfactory epithelium (OE) located in the superior parts of the nasal cavity below the cribriform plate (Figure 1). The OE is composed of several cell types including millions of olfactory sensory neurons (OSNs), in addition to microvillar, sustentacular cells, and basal cells, which are multipotent stem cells (). OSNs are bipolar neurons extending dendrites over the mucosa surface with axons passing through the cribriform plate to form synapses within glomeruli in the olfactory bulbs. Importantly, the OE is rich in basal stem cells, allowing OSNs to undergo continuous turnover during the life (). Odorant detection is mediated by a large multigene family that codes for olfactory receptors (ORs). ORs are G protein-coupled receptors (GPCRs) expressed within the membrane of OSN dendrites (). Myriads of chemically diverse odorants are discriminated in a combinatorial manner in which, one odorant activates a combination of ORs and one OR recognizes multiple odorants (; ). The main components of the canonical signal transduction pathway have been identified. The odorant-bound OR activates the olfactory specific G-protein α subunit, Gαolf, which in turn dissociates from Gβγ dimer and activates type III adenylyl cyclase (ACIII). ACIII activation leads to an increased production of cAMP causing the opening of a cyclic nucleotide-gated ion channel (CNG) resulting in neuron depolarization. OSNs project axons to the olfactory bulb located in the brain, where the axons synapse with bulb neurons (mitral and tufted cells). The olfactory information is then transmitted toward a great number of higher brain regions including at first piriform cortex, amygdala, olfactory tubercle, and entorhinal cortex; then to other regions such as orbitofrontal cortex, hypothalamus, thalamus, and hippocampus (Simon et al., 2006; ).

FIGURE 1

OE is covered by a thin layer of mucus secreted in the olfactory mucosa by the Bowman’s glands (). The mucus contains large concentrations of odorant-binding proteins (OBPs). OBPs are small soluble proteins secreted in the nasal mucus that reversibly bind odorant molecules (). While their physiological function is not fully understood, they are good candidates for carrying odorants, through the nasal mucus toward the olfactory receptors. The OE contains also many xenobiotic metabolizing enzymes (XMEs). XMEs constitute a large family of enzymes [including Glutathione-S-transferases (GSTs), UDP glucuronosyltransferase (UGT) and cytochrome P450 (CYP450)] that are highly expressed in the olfactory epithelium (). Although their functions in olfaction are still poorly understood, these enzymes are supposed to be involved in odorant transformation, degradation and/or olfactory signal termination (Schwartz et al., 2020).

The sense of taste is essential for the evaluation of the food quality in the oral cavity. It detects nutritive molecules such as carbohydrates or amino acids, electrolytes such as sodium or protons and potentially toxic molecules, which should be avoided (). The gustatory system allows perceiving five basic taste qualities, sweet, salty, sour, bitter, and umami (the taste of some amino acids such as L-glutamate and 5’-ribonucleotides). In addition to these five fundamental taste qualities, a number of other taste sensations including fat taste (; ), kokumi (mouthfulness in Japanese) taste () and calcium taste (; Tordoff et al., 2012) are still a matter of debate. Tasting substances are detected by 2,000–5,000 taste buds, which are located primarily on the tongue, soft palate, and epiglottis in mammals (). Taste buds contain specialized taste receptor-cells (TRCs) expressing specific taste receptors, which are stimulated by sapid molecules dissolved in saliva (). Like OSNs, TRCs are able to undergo continuous renewal throughout the life course ().

The detection of the sweet, bitter, and umami molecules is mediated by G-protein coupled receptors (GPCRs). The sweet taste receptor is composed of two subunits, TAS1R2 (taste receptor type 1, member 2) and TAS1R3 (taste receptor type 1, member 3). These subunits assemble to form a single sweet taste receptor () able to detect all the chemically diverse sweet-taste-eliciting chemicals. The bitter tasting compounds are detected in humans by a set of 25 different taste receptors (TAS2Rs) (). Whereas, some bitter receptors respond to only a few bitter compounds, other TAS2Rs are broadly tuned bitter receptors. The umami receptor is a heterodimer composed of TAS1R1 (taste receptor type 1, member 1) and TAS1R3, that assemble to detect the umami tastants (). The detection of sweet, umami and bitter molecules involves a common transduction mechanism. The main components of this signal cascade have been identified (). The binding of the tasting compounds to the receptors results in the dissociation of the heterotrimeric G protein (α-gustducin, Gβ3, and Gγ13). The release of the Gβγ protein induces an increase in phospholipase C-β2 (PLC-β2) activity. Activation of PLC-β2 results in the inositol 1,4,5-triphosphate (IP3) receptor, type 3-mediated release of calcium from intracellular stores and the gating of a transient receptor potential ion channel, TRPMP5 (). The epithelial Na+ channels (ENaCs) have been proposed to be the sodium receptor (), whereas, the proton channel Otopetrin-1 has been recently demonstrated to be the sour taste sensor (Tu et al., 2018).

Taste buds are innervated by three nerves, chorda tympani nerve (a branch of the facial nerve CN-VII), the glossopharyngeal (CN-IX) and vagus nerve (CN-X), conveying taste information to the nucleus tractus solitarius (NTS) within the central nervous system. From the NTS, the gustatory information is transmitted to numerous regions including the thalamus, for relay to the primary gustatory cortex located in the somatosensory cortex ().

The capacity of trigeminal nerve endings located in the nasal and oral cavity to detect the pungent or sharp feel, the coolness, the tingle or the irritation produced by different foods or beverages is called chemesthesis or trigeminal sensitivity (; Viana, 2011). They are detected by transient receptor potential (TRPs) channels, which are present on primary sensory neurons. The information is relayed to the brainstem via trigeminal ganglion sensory neurons (Roper, 2014). Chemesthetic stimuli are transduced by terminals of unmyelinated fibers traveling in trigeminal nerves (V) or by isolated chemosensory cells innervated by afferent axons traveling in these nerves, and possibly by epithelial keratinocytes, as discussed below.

It is then important to review what are the main mechanism by which SARS-COV-2 can affect smell and taste and what are the putative cells infected in these sensory systems.

SARS-CoV-2 and Anosmia: Cellular Tropism in Olfactory Epithelium

Cellular Expression of the Virus Receptor

ACE2 (angiotensin-converting enzyme 2) was characterized as the main entrance receptor for SARS-CoV-2 () interacting with its spike proteins. The spike protein allows the entrance into the host cell via a fusion domain (; ). This fusion domain is uncovered after maturation of the spike protein by both ACE2 and the transmembrane serine protease 2 (TMPRSS2). These proteins mainly direct the cellular sensitivity to SARS-CoV-2.

Both proteins are mainly expressed in the upper part of the respiratory tract () and the highest density of these proteins is found in the olfactory epithelium. Sustentacular cells express most of ACE2 and TMPRSS2 and these proteins are absent from OSN (; ). Both are also expressed to a lesser extent in Bowman’s gland, microvillar cells and basal stem cells (). Based on this expression profile, sustentacular cells seem to be the main target of the SARS-CoV-2 in the olfactory epithelium.

Interestingly, chemical disorders associated with COVID-19 seem to be linked to the ethnicity. A recent review reporting on nearly 40,000 patients across 104 studies found that anosmia (and ageusia) is more prevalent in Caucasians than Asians (54.8 vs. 17.7%, respectively) (von Bartheld et al., 2020). Such differences in chemical disorder susceptibility do not seem to be due to underreporting, but may be explained by virus strain differences among SARS-CoV-2 (D614G mutation) and/or ethnic variation in the frequencies of ACE2 and/or TMPRSS2 sequences giving more affinity of SARS-CoV-2 to Caucasians ().

Cellular Impact: in vivo Evidence of SARS-CoV-2 in the Olfactory System

Mouse

The first in vivo data on the cellular target of the SARS-CoV-2 came from earlier studies of SARS-CoV-1 impact on the central nervous system. These studies are interesting because SARS-CoV-1 and 2 share the same receptor and SARS-CoV-1 has been shown to be neurotropic in studies using ACE2 humanized mice (), thereby raising the possibility that SARS-CoV-2 could infect OSNs. Such infection would open a way for SARS-CoV-2 to enter the brain through the “olfactory pathway” (; ) and would explain the prevalence of encephalopathies observed in patients with COVID-19 (). However, many cells of these humanized mice ectopically express ACE2 as it is under the control of keratin 18 (K18) a promoter of all epithelial cells. SARS-CoV-1 may thus infect OSNs which physiologically do not express ACE2 and the observation of presence of the virus in the brain may not be relevant for a more physiological model. Thus, the mouse—usually favored due to all the different strains and genetic tools available—cannot be directly used to understand the cellular basis of SARS-CoV-2 induced anosmia. Better mouse models are in development to implement a humanized ACE2 with a physiological expression profile (; Sun et al., 2020). Recent studies using this model demonstrates that sustentacular cells and Bowman’s gland cells in the olfactory epithelium are the major targets of SARS-CoV-2 before the invasion into olfactory sensory neurons (Ye et al., 2020; Zheng et al., 2020). Nonetheless other animal models have proved to be relevant to unravel the cellular mechanism behind COVID-19 related anosmia.

Golden Syrian Hamsters

Golden Syrian hamsters have been successfully used as a model of SARS-CoV-1 infection (). Indeed, the expression profile and sequences of ACE2 are very similar in hamsters and humans (). The first study on SARS-CoV-2 impact on hamsters did not focus on anosmia, but provided some information on SARS-CoV-2 presence in the nasal cavity. The authors found that the virus was mainly infecting the olfactory epithelium in the nasal cavity and their results suggested that olfactory sensory neurons may be infected (Sia et al., 2020). Using the same animal model, we published shortly thereafter a study specifically focused on the impact of the SARS-CoV-2 in the nasal cavity (). Using confocal double label immunostaining, we observed a massive infection of sustentacular cells by SARS-CoV-2 as early as 2 days post-infection. This infection was accompanied by immune cell infiltration and a global desquamation of the OE. At 2 days post-infection, the lumen of the nasal cavity was filled with cellular aggregates containing infected sustentacular cells, olfactory neurons and immune cells. At 4 days post-infection, the number of infected sustentacular cells was greatly reduced while the olfactory epithelial thickness was reduced up to 80%. Furthermore, the remaining OSNs had mostly lost their cilia involved in odor detection. Seven days post-infection, the virus was almost completely absent from the nasal cavity and we observed a gradual recovery of the olfactory epithelial thickness which reached about 50% of that of the control 14 days after infection. This recovery was also observed for OSN cilia. While we did not measure olfactory based behavior in our study, the massive loss of OSN dendrites undoubtedly had an important impact on odor detection efficiency and could explain most of the observed anosmia symptom if similar cellular events occur in humans. The recovery kinetic is also consistent with the observed recovery of anosmia in COVID-19 patients. Indeed, most patients suffering from anosmia recover relatively fast (∼10 days) (; ; von Bartheld et al., 2020), which is compatible with the observed partial recovery of the olfactory epithelium in hamsters 14 days post-infection. These results were later confirmed by another group (Zhang et al., 2020); using a much higher virus load during infection (105 vs. 5.103 pfu in our study). This group looked carefully for a potential infection of OSN. They found that some mature and immature OSN can be infected by SARS-CoV-2 but the study presents only a few images and this infection may be exceptionally rare compared to the occurrence of sustentacular cells infection. The infection of immature neurons could impair regeneration. Similar to other studies (; Sia et al., 2020), Zhang et al. (2020) did not find any presence of the virus in the olfactory bulb indicating that if infection of OSN did occur, it did not lead to a detectable presence of the virus in the brain. Thus, so far, the possibility that SARS-CoV-2 could enter the brain through the “olfactory pathway” remains to be demonstrated.

Other Animal Models and Human Biopsies

Ferrets are also classically used as a model for respiratory viruses, especially influenza (). The first study on ferrets infected with SARS-CoV-2 did not specifically focus on the olfactory epithelium; however, when they observed the presence of the virus in the nasal cavity, they found only infection of respiratory epithelial cells (Ryan et al., 2020). This result was confirmed in a broader study including fruit bats, pigs and chickens (Schlottau et al., 2020). While both pigs and chicken were resistant to SARS-CoV-2 infection, the fruit bat was susceptible but only few respiratory cells were infected by the virus. The authors observed, however, cellular debris in the lumen of the nasal cavity for both fruit bats and ferrets similarly to reports with infected golden Syrian hamsters.

Data from human biopsies are scarce, and they do not provide a link between the cellular tropism of SARS-CoV-2 to the observed anosmia. Some studies explored olfactory epithelium obtained from autopsied patients with COVID-19 patients. Results are rather controversial so far. A study performed on four samples did not find the virus in the olfactory epithelium by immunohistochemistry (). A study based on 33 samples from autopsied patients explored specifically the presence of the virus by RT-qPCR (). They observed the presence of the virus in the olfactory epithelium in 20 patients (∼60%) and in the olfactory bulb in 3 (∼10%). While the authors conclude that SARS-CoV-2 must thus infect OSN allowing it to enter the brain through olfactory bulb invasion, the study does not present any evidence of the presence of infected neurons by immunohistochemistry in the olfactory bulb. Another study focused on biopsies from olfactory epithelium of living COVID-19 positive patients (). In this work, the authors only observed the presence of a few SARS-CoV-2 infected macrophages in the olfactory epithelium but no other cells were found SARS-CoV-2 positive. However, the delay between biopsies and SARS-CoV-2 infection detection was not presented in this study. As biopsies were harvested from patients already suffering from anosmia, it could be that they were performed several days after the onset of the COVID-19 infection and the virus could then be already mostly eliminated from the nasal cavity if a similar kinetic of virus clearance from the nasal cavity occurs in hamsters and humans. If so, earlier human biopsies could be very informative as the virus would be present and impact the olfactory epithelium mostly during the first 4 days following infection. Thus, so far more studies are required to evaluate to which extent the impact of SARS-CoV-2 on the olfactory epithelium differs from the model based on the hamster study. The fact that very few studies observed the presence of SARS-CoV-2 in human OSNs indicates that it may be a rare occurrence (; ). In any case, it must be noted that the very rapid recovery of smell usually described in both humans and rodents may not be consistent with the timing of olfactory neuron regeneration (which is thought to take 10 or more days; ; ). However, as the onset of infection is very difficult to assess in humans, further studies are required to understand these events.

Models to Explain COVID-19 Related Anosmia

Overall, most data indicate that the main targets of SARS-CoV-2 in the olfactory epithelium are sustentacular cells. Following their infection, most of the olfactory epithelium seems to be lost by desquamation as indicated by the presence of cellular debris in the lumen of the nasal cavity from numerous studies. This desquamation will remove part of the OSN population but could be accompanied by a loss of the dendrite layer of OSN where olfactory transduction occurs. These two consequences of the SARS-CoV-2 infection could explain the anosmia observed in COVID-19 patient. Subsequently two different scenarios could occur according to the physiological state of the infected individuals as well as the initial virus load. However, in healthy individuals the recovery would be fast due to the basal cells regenerating the olfactory epithelium. This recovery may be impaired by several factors:

  • Individuals characteristics. Indeed, aged and/or overweight individuals are much more susceptible to COVID-19 (Simonnet et al., 2020). The olfactory epithelium integrity declines with age () and overweight individual often present an increased basal inflammation state in their tissue () which could also impair regeneration (; Sultan et al., 2011). Infection by SARS-CoV-2 of olfactory epithelium already in an inflammation state may facilitate the virus infection efficiency as its receptor ACE2 is overexpressed during inflammation (Ziegler et al., 2020).

  • Initial virus load. OSN seems to be infected only with higher virus loads. If this infection reaches a certain threshold, it could begin to affect immature OSNs which will impact the regeneration of the olfactory epithelium.

  • Invasion of the respiratory epithelium. Part of the olfactory epithelium can be replaced by respiratory epithelium as usually observed in post viral olfactory disorders (). It would diminish the recovery from anosmia.

This model is summarized in Figure 2. Many questions remain to elucidate the mechanism behind this desquamation.

FIGURE 2

Is it simply due to the destruction of sustentacular cells following SARS-CoV-2 infection? Indeed, these cells are essential to maintain the integrity of the olfactory epithelium and are tightly enwrapped around olfactory sensory neurons (). Their disappearance from the olfactory epithelium will certainly impact the olfactory sensory neurons integrity; at least the dendrite layer, if not the cell body as well.

What is the role of the immune cells infiltrating the olfactory epithelium following infection? Are they actively involved in the desquamation of the olfactory epithelium or do they invade the olfactory epithelium following chemo-attractive signals after sustentacular infection and destruction? Indeed, as expected, inflammatory signals are increased in the olfactory epithelium following SARS-CoV-2 infection ().

SARS-CoV-2 and Ageusia: Cellular Tropism in Taste Buds

Unlike anosmia, COVID-induced ageusia has drawn much less interest in the scientific community, probably because to date, infection of the taste buds has been mostly overlooked. One study on the rabies virus impact in dogs found that taste buds were infected (Shiwa et al., 2018). The virus may reach the taste buds by retrograde transport from the infected brain. Thus, unlike anosmia which could be linked to a potential invasion of the brain through the olfactory nerve, an infection of taste buds which do not contain neurons may not be threatening for the infected individual.

Nevertheless, understanding how SARS-CoV-2 could impact gustation as frequently as olfaction may reveal unsuspected virus-host interactions. ACE2 was suspected to be expressed mainly outside the taste buds (). This was confirmed by a comprehensive study of the ACE2 expression profile in mice tongue showing that ACE2 is mainly expressed in epithelial cells outside of taste papillae which contain the taste buds (Wang et al., 2020). According to this study, taste buds are thus very unlikely to be directly impacted by the SARS-CoV-2 which may instead infect cells distant from taste buds.

Models to Explain COVID-19 Related Ageusia

In order to improve our understanding of the cellular basis of ageusia, studies on the oral cavity impact of SARS-CoV-2 in model animals are required. In their absence, only a hypothetical scenario based on other pathological ageusia can be drawn.

One explanation of the SARS-CoV-2 induced ageusia could be that taste nerves are damaged following central nervous infection by SARS-CoV-2. It seems unlikely as a recent study performed in human indicates that impairments of chemical senses are correlated with low severity in COVID-19 patients excluding encephalitis () and the prevalence of central nervous damage by SARS-CoV-2 remains limited ().

The taste buds have a fast turnover as they are renewed within approximately 10 days (). Another explanation could thus be that following infection of epithelial cells in the tongue, inflammatory cytokines could reach the taste buds impairing their renewal. Indeed, Toll-like receptors (TLR) and interferon (IFN) receptors are highly expressed in taste buds and their activation may limit taste cell regeneration (Wang et al., 2007, 2009). Thus, ageusia could be the result of impaired renewal of taste buds following the cytokines storm induced by SARS-CoV-2 in distant cells. The cytokine storm could also make taste buds cells permissive to SARS-CoV-2. Indeed, ACE2 has been shown to be overexpressed in the presence of IFN (Ziegler et al., 2020). Thus, a distant production of IFN from infected keratinocytes could lead to ACE2 expression in taste bud cells which could in turn be infected by SARS-CoV-2. A last explanation could be that taste nerves are damaged following central nervous infection by SARS-CoV-2. However, this seems unlikely, because the prevalence of central nervous system damage by SARS-CoV-2 remains limited () while the prevalence of ageusia is high. Furthermore, COVID-19 patients suffering from impairments of chemical senses develop low severity symptoms excluding encephalitis ().

Impact of Anosmia and Ageusia in COVID-19 on Feeding Behavior

Role of Flavor in Eating Behavior in Physiological Conditions

Smell and taste make an important contribution to the general appetite, food choice, the onset of satiation, thereby participating in the control of energy intake allows an organism to connect the structural and chemical properties of foods to palatability and the foods’ underlying nutritional value (Figure 3). Therefore, the sensory perception resulting from taste, odor and texture of the food, that is, its flavor, allows us to decide to ingest the food or not (Ventura and Worobey, 2013).

FIGURE 3

Olfaction, despite being perceptually intertwined with taste to produce the food flavor, has different independent physiological mechanisms, neural circuits and effects on food selection and intake (). While taste is based on a small class of receptors to detect a few important chemicals of the food once it is in the mouth, olfaction uses many receptors to detect thousands of different smells before and during intake in order to identify a wide variety of foods. Food odor has an important impact on general appetite: it can influence the quality and quantity of food chosen (; ) and stimulate appetite, even in the absence of hunger (). It has also been suggested that there is a quality-specific effect of each odor that influences food choices (). Food odors also seem to stimulate sensory specific appetite (), motivate spontaneous consumption behaviors and help to distinguish different food sources. Some studies have observed that food odors could enhance the onset of satiation and reduce food intake (). Perceived odor intensity during food intake influences the quantity of eaten food (): if food odor is perceived more intense, food consumption will be reduced. Food aromas are also signals associated with both food’s availability and pleasure. Consequently, food aromas under fasting conditions and in obesity induce activation of several regions implicated in the reward system according to fMRI’s (functional magnetic resonance imaging) studies (; ) and in contrast, decrease their activation in anorexia nervosa ().

Food taste plays an important role in the control of food intake and taste intensity may stimulate satiation (). In fact, when food enters directly the stomach without being processed by the taste receptors, satiation and reward values are lower (Wijlens et al., 2012; Spetter et al., 2014). Taste is commonly referred to as the body’s “nutritional gatekeeper” of food intake (). Indeed, the sense of taste is an important factor in food seeking behaviors and dietary intake. Each taste quality has been associated with specific nutrients: sweet taste to identify sources of carbohydrates, sour for the presence of vitamins, salty for the presence of electrolytes and umami for source of proteins (Tucker and Mattes, 2012). In contrast, the bitter taste prevents the ingestion of toxic or spoiled substances (Tucker and Mattes, 2012). All basic tastes, combined with food odors to form flavor, influence food intake and satiation. Numerous studies reported the effect of other taste modalities on the stimulation on food intake. For example, salt enhances palatability and can motivate food intake and then lead to satiation (). Umami is also known to stimulate palatability, appetite, the desire to eat, and therefore food intake (Simpson and Raubenheimer, 2005; ). Sweetness contributes to the palatability of food and enhances food intake by increasing its acceptance, especially in children (; ). To illustrate the role of sweet taste, a systematic review reports that in healthy subjects, a strong hedonic preference for sweetness increases the energy intake from sweet foods, especially in subjects with sweet lovers’ phenotypes (Tan and Tucker, 2019). Conversely, a high sensitivity to sweetness (low detection and recognition thresholds) is associated with a low consumption of carbohydrate-rich foods associated with a higher intake of non-sweet foods and dietary protein (). Similarly, a strong perception of the intensity of sweetness decreases total energy intake and the consumption of carbohydrate-rich foods (). These observations indicate that inter-individual differences in sweetness perception (sensitivity and intensity) seem to have a weak and even opposing influence on carbohydrate intakes, in contrast to the sweet induced pleasure which has a great influence on consumption (Tan and Tucker, 2019).

The multisensory properties of food stimuli are transmitted to the brain through specialized taste, olfactory and somatosensory pathways that converge on several central nervous system centers involved in homeostatic and hedonic control of food intake. Hedonic factors that participate in the control of eating behavior by four classic mechanisms (conditioned satiety, food reward system, sensory specific satiety, and alliesthesia) are directly linked to taste and olfaction, and reinforce the flavor pleasantness of food.

Role of Flavor in Eating Behavior in Pathophysiological Conditions

Taste and smell dysfunctions are common clinical problems associated with disease processes but are often neglected (). Yet deficits in taste and olfactory chemical senses have a severe impact on the pleasure from foods and represent risk factors for nutritional deficiencies. Causes of smell, taste, and oral somatosensory disorders that affect intakes are numerous: aging, chronic nasal-sinus disease, upper respiratory tract infection, pathologies of the middle ear, head trauma, neurodegenerative disorders, obesity, liver and kidney diseases, cancer, environmental chronic exposures, medications, oral health, surgical interventions, infections and nutritional intervention for chemosensory disorders (for reviews see Schiffman, 1997, 2018; ; ).

Several studies observed that the coronavirus causing COVID-19 is responsible for smell and taste dysfunctions (; ; von Bartheld et al., 2020). Some studies have reported that 11% of COVID-19 patients with smell loss have chronic deficits, with a chemosensory dysfunction that persists beyond 4 weeks after onset (). Accordingly, the current number of such patients worldwide can be estimated. This unprecedent magnitude of the number of cases emphasizes the importance of understanding the clinical consequences of loss of smell/taste.

It was suggested that SARS-CoV-2 is a neurotropic and neuro-invasive virus, by infecting peripheral neurons and then by spreading into the central nervous system like other neuroinvasive viruses (). Concerning the smell functions, the virus may invade the olfactory nerves and the olfactory bulb, causing, on the one hand, olfactory epithelium desquamation and olfactory bulb atrophy, and on the other hand olfactory bulb inflammation (). Concerning the taste functions, the viral infection and inflammatory response may lead to disruption of saliva composition, taste transduction and impair the continuous renewal of taste buds. Some investigators proposed that the coronavirus causing COVID-19 could also target cells of the central nervous system (). It has also been observed that another coronavirus (SARS-CoV) might enter the central nervous system through the olfactory bulb to spread to some brain areas which are particularly vulnerable to this virus family: piriform and infralimbic cortices, ventral pallidum and lateral preoptic regions in the basal ganglia, and dorsal raphe nuclei in the midbrain (). But as already mentioned a limitation of this study is that it was performed on humanized mice expressing ACE-2 in every epithelial cell.

The influence of hypogeusia (dysgeusia) and/or hyposmia (dysosmia) during COVID-19 on food/energy intake or food preferences has not yet been reported. At the most, literature discusses changes in feeding behavior during the lockdown period, without direct relationship with COVID-19, but in the context of sudden lifestyle changes (; ).

To demonstrate the putative impact of smell and taste disorders in COVID-19 on feeding behavior, we can consider examples of other well-known pathological situations causing the same sensory perturbances. For example, taste and smell alterations resulting from cancers and chemotherapy can reduce appetite and contribute to poor nutritional status (; ). In the same way, olfactory dysfunctions in Parkinson disease can lead to changes in feeding behavior ().

Taking into account the potential neurological damage caused by the COVID-19 infection, it is understandable that this virus could have a strong impact on feeding behavior, mediated by taste and smell dysfunctions, and possibly the spreading of the virus to brain regions implicated in hedonic controls of food intake. We can hypothesize that this viral infection, depending on the severity of symptoms, could alter alimentary consumption and nutritional status as in the above-cited pathologies. Indeed, decreases of taste and/or smell may alter the hedonic response associated with the sensory sensations and, therefore, the response to the sensory experience of eating (). Putative mechanisms could be a decrease in conditioned satiety (misperception of the aliment before intake), a decrease in the reward system (i.e., low liking and wanting for foods during ingestion) and an early sensory specific satiety (premature termination of the consumed food) ().

The consequence of a decrease in energy intake would then be weight loss (associated with other nutritional imbalances). Studies conducted on animals indicated that SARS-CoV-2 causes weight loss associated with an increase in inflammatory cytokines (). In humans, COVID-19 causes anorexia, weight loss and low albumin levels. The variation between infected individuals is immense; some subjects are asymptomatic or with minimal symptoms, while others develop a severe or even fatal course of the disease. Many factors have been identified in weight loss and sarcopenia/cachexia (). Furthermore, many confounding factors (independent of the increase in energy expenditure related to inflammatory phenomena) may interfere with weight changes linked to taste and smell dysfunctions and food intake reduction, and may be related to change in food and physical activity, sleeping habits, anxiety and depression (; ; ; ; Zachary et al., 2020). Thus, in absence of studies investigating the direct effect of smell and taste dysfunctions on food intake and preference, it is difficult to quantify precisely their effect in humans. Indeed all these considerations are primarily relevant for the fraction of COVID cases with chronic, not acute loss of smell and taste.

Conclusion

The relationships between the chemical senses and physiological regulation of food intake are well-known and documented. Even in the absence of relevant studies on the effect of taste and smell alterations on food consumption during COVID-19, special attention should be paid during this period to high-risk individuals with food sensory disturbances, i.e., those with co-morbidities (cardiac, hepatic, and renal), sarcopenia, diabetes, hypertension, smoking, eating disorders, and malnutrition, as well as the elderly. It is crucial to prevent a decrease in food intake during COVID-19 pandemic (; ).

Statements

Author contributions

NM, LoB, AJ-P, LaB, and LP discussed the concepts, wrote parts, and reviewed the entire manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by grants from the Conseil Régional Bourgogne, Franche-Comté (PARI grant) and the FEDER (European Funding for Regional Economical Development).

Acknowledgments

We deeply thanks the two reviewers for their comments and suggestions that greatly help us to ameliorate the manuscript.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Summary

Keywords

COVID 19, taste, smell, feeding behavior, physiopathology

Citation

Meunier N, Briand L, Jacquin-Piques A, Brondel L and Pénicaud L (2021) COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology. Front. Physiol. 11:625110. doi: 10.3389/fphys.2020.625110

Received

02 November 2020

Accepted

31 December 2020

Published

26 January 2021

Volume

11 - 2020

Edited by

Georges Leftheriotis, Université Côte d’Azur, France

Reviewed by

Christopher von Bartheld, University of Nevada, Reno, United States; Kathleen S. Curtis, Oklahoma State University Center for Health Sciences, United States

Updates

Copyright

*Correspondence: Luc Pénicaud,

This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics